Erythrocytes as Drug Carriers in Medicine:
The sixth meeting on the use of resealed annealed red blood cells was held in Irsee, Germany by the International Society for the Use of Resealed Erythrocytes (ISURE) on July 25-28, 1996. Although earlier meetings focused on the technology toward develop ment of methods and standardization for effi...
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Boston, MA
Springer US
1997
|
| Schlagworte: | |
| Online-Zugang: | UBR01 URL des Erstveröffentlichers |
| Zusammenfassung: | The sixth meeting on the use of resealed annealed red blood cells was held in Irsee, Germany by the International Society for the Use of Resealed Erythrocytes (ISURE) on July 25-28, 1996. Although earlier meetings focused on the technology toward develop ment of methods and standardization for efficient, consistent encapsulation, most of the present studies now are directed toward the application use of these carrier blood cells. Basic studies now have been directed toward exploration of commercial applications. In deed, clinical trials were initiated to evaluate the dose-response curves employing L asparagenase in human patients. Also, studies have shown the use of thrombolytic agent in erythrocyte carriers with the use of human red blood cells to provide a new conceptual ap proach in thrombolytic therapy to prevent thrombosis in individuals with higher risk fac tors. For example, with the use of carrier red blood cells, the thrombolytic agents will have a greater potential of acting on clot formation without systemic activation and thus lower the risk of hemorrhage, which is always prevalent in the thrombolytic therapy |
| Beschreibung: | 1 Online-Ressource (VIII, 150 p) |
| ISBN: | 9781489900449 |
| DOI: | 10.1007/978-1-4899-0044-9 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV046144015 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190905s1997 |||| o||u| ||||||eng d | ||
| 020 | |a 9781489900449 |9 978-1-4899-0044-9 | ||
| 024 | 7 | |a 10.1007/978-1-4899-0044-9 |2 doi | |
| 035 | |a (ZDB-2-SME)978-1-4899-0044-9 | ||
| 035 | |a (OCoLC)1118997401 | ||
| 035 | |a (DE-599)BVBBV046144015 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.15 |2 23 | |
| 245 | 1 | 0 | |a Erythrocytes as Drug Carriers in Medicine |c edited by Ulrich Sprandel, James L. Way |
| 246 | 1 | 3 | |a Proceedings of the Sixth Meeting of the International Society for the Use of Resealed Erythrocytes held in Irsee, Germany, July 25-28, 1996 |
| 264 | 1 | |a Boston, MA |b Springer US |c 1997 | |
| 300 | |a 1 Online-Ressource (VIII, 150 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 520 | |a The sixth meeting on the use of resealed annealed red blood cells was held in Irsee, Germany by the International Society for the Use of Resealed Erythrocytes (ISURE) on July 25-28, 1996. Although earlier meetings focused on the technology toward develop ment of methods and standardization for efficient, consistent encapsulation, most of the present studies now are directed toward the application use of these carrier blood cells. Basic studies now have been directed toward exploration of commercial applications. In deed, clinical trials were initiated to evaluate the dose-response curves employing L asparagenase in human patients. Also, studies have shown the use of thrombolytic agent in erythrocyte carriers with the use of human red blood cells to provide a new conceptual ap proach in thrombolytic therapy to prevent thrombosis in individuals with higher risk fac tors. For example, with the use of carrier red blood cells, the thrombolytic agents will have a greater potential of acting on clot formation without systemic activation and thus lower the risk of hemorrhage, which is always prevalent in the thrombolytic therapy | ||
| 650 | 4 | |a Hematology | |
| 650 | 4 | |a Hematology | |
| 650 | 0 | 7 | |a Arzneistoffträger |0 (DE-588)4278196-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Erythrozyt |0 (DE-588)4070945-0 |2 gnd |9 rswk-swf |
| 655 | 7 | |8 1\p |0 (DE-588)1071861417 |a Konferenzschrift |y 1996 |z Irsee |2 gnd-content | |
| 689 | 0 | 0 | |a Erythrozyt |0 (DE-588)4070945-0 |D s |
| 689 | 0 | 1 | |a Arzneistoffträger |0 (DE-588)4278196-6 |D s |
| 689 | 0 | |8 2\p |5 DE-604 | |
| 700 | 1 | |a Sprandel, Ulrich |4 edt | |
| 700 | 1 | |a Way, James L. |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781489900463 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780306455995 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781489900456 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-1-4899-0044-9 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_1990/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031524198 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u https://doi.org/10.1007/978-1-4899-0044-9 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804180478857576448 |
|---|---|
| any_adam_object | |
| author2 | Sprandel, Ulrich Way, James L. |
| author2_role | edt edt |
| author2_variant | u s us j l w jl jlw |
| author_facet | Sprandel, Ulrich Way, James L. |
| building | Verbundindex |
| bvnumber | BV046144015 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-1-4899-0044-9 (OCoLC)1118997401 (DE-599)BVBBV046144015 |
| dewey-full | 616.15 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.15 |
| dewey-search | 616.15 |
| dewey-sort | 3616.15 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-1-4899-0044-9 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03281nmm a2200529zc 4500</leader><controlfield tag="001">BV046144015</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1997 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781489900449</subfield><subfield code="9">978-1-4899-0044-9</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-4899-0044-9</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-1-4899-0044-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1118997401</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046144015</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.15</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Erythrocytes as Drug Carriers in Medicine</subfield><subfield code="c">edited by Ulrich Sprandel, James L. Way</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Proceedings of the Sixth Meeting of the International Society for the Use of Resealed Erythrocytes held in Irsee, Germany, July 25-28, 1996</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boston, MA</subfield><subfield code="b">Springer US</subfield><subfield code="c">1997</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (VIII, 150 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The sixth meeting on the use of resealed annealed red blood cells was held in Irsee, Germany by the International Society for the Use of Resealed Erythrocytes (ISURE) on July 25-28, 1996. Although earlier meetings focused on the technology toward develop ment of methods and standardization for efficient, consistent encapsulation, most of the present studies now are directed toward the application use of these carrier blood cells. Basic studies now have been directed toward exploration of commercial applications. In deed, clinical trials were initiated to evaluate the dose-response curves employing L asparagenase in human patients. Also, studies have shown the use of thrombolytic agent in erythrocyte carriers with the use of human red blood cells to provide a new conceptual ap proach in thrombolytic therapy to prevent thrombosis in individuals with higher risk fac tors. For example, with the use of carrier red blood cells, the thrombolytic agents will have a greater potential of acting on clot formation without systemic activation and thus lower the risk of hemorrhage, which is always prevalent in the thrombolytic therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hematology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hematology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneistoffträger</subfield><subfield code="0">(DE-588)4278196-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Erythrozyt</subfield><subfield code="0">(DE-588)4070945-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1996</subfield><subfield code="z">Irsee</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Erythrozyt</subfield><subfield code="0">(DE-588)4070945-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneistoffträger</subfield><subfield code="0">(DE-588)4278196-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sprandel, Ulrich</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Way, James L.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781489900463</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780306455995</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781489900456</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-4899-0044-9</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031524198</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4899-0044-9</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | 1\p (DE-588)1071861417 Konferenzschrift 1996 Irsee gnd-content |
| genre_facet | Konferenzschrift 1996 Irsee |
| id | DE-604.BV046144015 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:24Z |
| institution | BVB |
| isbn | 9781489900449 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031524198 |
| oclc_num | 1118997401 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (VIII, 150 p) |
| psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
| publishDate | 1997 |
| publishDateSearch | 1997 |
| publishDateSort | 1997 |
| publisher | Springer US |
| record_format | marc |
| spelling | Erythrocytes as Drug Carriers in Medicine edited by Ulrich Sprandel, James L. Way Proceedings of the Sixth Meeting of the International Society for the Use of Resealed Erythrocytes held in Irsee, Germany, July 25-28, 1996 Boston, MA Springer US 1997 1 Online-Ressource (VIII, 150 p) txt rdacontent c rdamedia cr rdacarrier The sixth meeting on the use of resealed annealed red blood cells was held in Irsee, Germany by the International Society for the Use of Resealed Erythrocytes (ISURE) on July 25-28, 1996. Although earlier meetings focused on the technology toward develop ment of methods and standardization for efficient, consistent encapsulation, most of the present studies now are directed toward the application use of these carrier blood cells. Basic studies now have been directed toward exploration of commercial applications. In deed, clinical trials were initiated to evaluate the dose-response curves employing L asparagenase in human patients. Also, studies have shown the use of thrombolytic agent in erythrocyte carriers with the use of human red blood cells to provide a new conceptual ap proach in thrombolytic therapy to prevent thrombosis in individuals with higher risk fac tors. For example, with the use of carrier red blood cells, the thrombolytic agents will have a greater potential of acting on clot formation without systemic activation and thus lower the risk of hemorrhage, which is always prevalent in the thrombolytic therapy Hematology Arzneistoffträger (DE-588)4278196-6 gnd rswk-swf Erythrozyt (DE-588)4070945-0 gnd rswk-swf 1\p (DE-588)1071861417 Konferenzschrift 1996 Irsee gnd-content Erythrozyt (DE-588)4070945-0 s Arzneistoffträger (DE-588)4278196-6 s 2\p DE-604 Sprandel, Ulrich edt Way, James L. edt Erscheint auch als Druck-Ausgabe 9781489900463 Erscheint auch als Druck-Ausgabe 9780306455995 Erscheint auch als Druck-Ausgabe 9781489900456 https://doi.org/10.1007/978-1-4899-0044-9 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Erythrocytes as Drug Carriers in Medicine Hematology Arzneistoffträger (DE-588)4278196-6 gnd Erythrozyt (DE-588)4070945-0 gnd |
| subject_GND | (DE-588)4278196-6 (DE-588)4070945-0 (DE-588)1071861417 |
| title | Erythrocytes as Drug Carriers in Medicine |
| title_alt | Proceedings of the Sixth Meeting of the International Society for the Use of Resealed Erythrocytes held in Irsee, Germany, July 25-28, 1996 |
| title_auth | Erythrocytes as Drug Carriers in Medicine |
| title_exact_search | Erythrocytes as Drug Carriers in Medicine |
| title_full | Erythrocytes as Drug Carriers in Medicine edited by Ulrich Sprandel, James L. Way |
| title_fullStr | Erythrocytes as Drug Carriers in Medicine edited by Ulrich Sprandel, James L. Way |
| title_full_unstemmed | Erythrocytes as Drug Carriers in Medicine edited by Ulrich Sprandel, James L. Way |
| title_short | Erythrocytes as Drug Carriers in Medicine |
| title_sort | erythrocytes as drug carriers in medicine |
| topic | Hematology Arzneistoffträger (DE-588)4278196-6 gnd Erythrozyt (DE-588)4070945-0 gnd |
| topic_facet | Hematology Arzneistoffträger Erythrozyt Konferenzschrift 1996 Irsee |
| url | https://doi.org/10.1007/978-1-4899-0044-9 |
| work_keys_str_mv | AT sprandelulrich erythrocytesasdrugcarriersinmedicine AT wayjamesl erythrocytesasdrugcarriersinmedicine AT sprandelulrich proceedingsofthesixthmeetingoftheinternationalsocietyfortheuseofresealederythrocytesheldinirseegermanyjuly25281996 AT wayjamesl proceedingsofthesixthmeetingoftheinternationalsocietyfortheuseofresealederythrocytesheldinirseegermanyjuly25281996 |